GYRE Change in Working Capital
Gyre Therapeutics Inc · Change in Working Capital
GYRE Change in Working Capital
Latest reported$2.16Mperiod ending
GYRE TTM Change in Working Capital ($1.65M → $2.16M)
TTM change in working capital
High-resolution chart · PNG
GYRE change in working capital history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Change in Working Capital (USD) |
|---|---|
| 2,157,000 | |
| -2,694,000 | |
| -15,554,000 | |
| -9,709,000 | |
| -9,181,000 | |
| -16,277,000 | |
| -15,688,000 | |
| -10,600,000 | |
| -9,295,000 | |
| -1,253,000 | |
| 7,458,000 | |
| 6,397,000 | |
| 4,250,000 | |
| -3,501,000 | |
| -8,616,804 | |
| -7,167,804 | |
| -1,560,804 | |
| 4,310,196 | |
| 483,000 | |
| -5,543,999 | |
| -6,468,999 | |
| -3,993,999 | |
| -2,571,999 | |
| 6,416,000 | |
| 7,273,000 | |
| 7,397,000 | |
| 8,215,000 | |
| 4,442,000 | |
| 1,596,000 | |
| -1,298,000 | |
| -1,369,000 | |
| -3,342,000 | |
| -2,770,000 | |
| 69,000 | |
| 567,000 | |
| 2,338,000 | |
| 1,309,000 | |
| 964,000 | |
| 1,330,000 | |
| 645,000 | |
| 933,000 | |
| 252,000 | |
| -79,000 | |
| -240,000 | |
| -3,932,000 | |
| -4,195,861 | |
| -3,926,000 | |
| -3,255,000 | |
| 2,293,000 | |
| 2,491,861 | |
| 2,738,000 | |
| 5,102,000 | |
| -510,000 | |
| -2,902,000 | |
| -10,220,000 | |
| -7,927,000 | |
| 2,699,000 | |
| 1,795,000 | |
| 10,346,000 | |
| 12,634,000 | |
| 6,541,000 | |
| 23,346,000 | |
| 207,319,000 | |
| 215,130,000 | |
| 215,679,000 | |
| 205,205,000 | |
| 17,227,000 | |
| 7,642,278 | |
| 4,957,389 | |
| -901,366 | |
| -164,000 | |
| 976,624 | |
| 25,929,879 | |
| 28,941,451 | |
| 49,299,163 | |
| 20,720,861 | |
| -2,440,826 | |
| -2,591,662 | |
| -13,325,599 | |
| 10,164,669 | |
| 10,139,688 | |
| 9,738,814 | |
| 1,654,015 |